Samrat Remedies India Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 02-07-2024
- Paid Up Capital ₹ 0.10 M
as on 02-07-2024
- Company Age 39 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 13.05 Cr
as on 02-07-2024
- Satisfied Charges ₹ 3.60 Cr
as on 02-07-2024
- Revenue 42.25%
(FY 2023)
- Profit 254.69%
(FY 2023)
- Ebitda 22.97%
(FY 2023)
- Net Worth 843.84%
(FY 2023)
- Total Assets -13.73%
(FY 2023)
About Samrat Remedies India
The Corporate was formerly known as Zh Chemicals Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹13.05 Cr. The company has closed loans amounting to ₹3.60 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sangeeta Parekh and Hitesh Parekh serve as directors at the Company.
- CIN/LLPIN
U24100MH1985PTC035969
- Company No.
035969
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Apr 1985
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Samrat Remedies India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sangeeta Parekh  | Director | 24-May-2013 | Current |
| Hitesh Parekh | Director | 24-May-2013 | Current |
Financial Performance of Samrat Remedies India.
Samrat Remedies India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 42.25% increase. The company also saw a substantial improvement in profitability, with a 254.69% increase in profit. The company's net worth Soared by an impressive increase of 843.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Samrat Remedies India?
In 2023, Samrat Remedies India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 13 Aug 2014 | ₹13.05 Cr | Open |
Others Creation Date: 23 Oct 2020 | ₹3.60 Cr | Satisfied |
How Many Employees Work at Samrat Remedies India?
Samrat Remedies India has a workforce of 22 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Samrat Remedies India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Samrat Remedies India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
